Trial intelligence / Profile preview

Tranexamic acid in Intracerebral Haemorrhage (TICH)

2010-022009-16Phase 2Completed

Sponsor
University of Nottingham
Start
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of tranexamic acid in Primary Intracerebral Hemorrhage (ICH) (2 arms), sponsored by University of Nottingham. Primary endpoints: Feasibility and Tolerability and acceptability (adverse events). Started Aug 2010; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Primary Intracerebral Hemorrhage (ICH)

Beyond the preview

Go deeper on 2010-022009-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022009-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call